Cingulate Inc. is projected to decline to $3.79 by 2027, a -4% move from its current price of $3.96. CING is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.73 | $3.96 | $4.19 | -0.12% |
| May 30 | $3.64 | $3.95 | $4.29 | -0.24% |
| May 31 | $3.56 | $3.95 | $4.37 | -0.36% |
| Jun 1 | $3.51 | $3.94 | $4.43 | -0.47% |
| Jun 2 | $3.45 | $3.94 | $4.49 | -0.59% |
| Jun 3 | $3.41 | $3.93 | $4.54 | -0.71% |
| Jun 4 | $3.36 | $3.93 | $4.59 | -0.83% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.36 | $3.93 | $4.59 | -0.83% |
| Week 2 | $3.13 | $3.89 | $4.85 | -1.65% |
| Week 3 | $2.95 | $3.86 | $5.05 | -2.46% |
| Week 4 | $2.81 | $3.83 | $5.22 | -3.27% |
| Week 5 | $2.69 | $3.80 | $5.37 | -4.07% |
| Week 6 | $2.58 | $3.77 | $5.51 | -4.87% |
| Week 7 | $2.48 | $3.74 | $5.63 | -5.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cingulate Inc. (CING) is a biopharmaceutical company that develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
Its lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD.
Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. is trading in the healthcare sector with a current price of $3.96 and a market capitalization of $52.57M. The company is ranked 4517 by market size.
The near-term outlook shows a flat-to-moderate drift in value, with the annual forecast suggesting gradual upside later in the forecast horizon. For example, the 2026 avg is $3.96 and the 2029 avg is $5.03, progressing to a 2030 avg of $6.22 and a max of $10.84.
Over the longer horizon, the forecast extends to 2050 with an avg of $16.45 and a max of $37.84, implying meaningful upside (ROI 315.5) in a bullish longer-term scenario.
A major floor 34.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 52.3% above — a clean break opens room to run.
A major ceiling 194.4% above — clearing it would confirm fresh momentum.
Key CING support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CING market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.52 | Sell | $4.42 | Sell |
| MA 10 | $4.53 | Sell | $4.56 | Sell |
| MA 20 | $4.82 | Sell | $4.81 | Sell |
| MA 50 | $5.66 | Sell | $5.35 | Sell |
| MA 100 | $5.93 | Sell | $5.46 | Sell |
| MA 200 | $4.90 | Sell | $5.63 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.83 | Neutral |
| Stoch RSI (14) | 2.19 | Buy |
| CCI (20) | -185.01 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -24.86 | Sell |
| Bollinger %B (20,2) | -0.08 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.90 | Sell |
| Awesome (5,34) | -0.58 | Sell |
| Ultimate (7,14,28) | 33.86 | Neutral |
| Momentum (10) | -0.83 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 4.49 | Sell |
| ADX (14) | 18.42 | Neutral |
| ATR (14) | 0.28 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40, with SMA50 at $5.66 and SMA200 at $4.90. Price currently has support at $3.96 and resistance at $6.03.
The 30-day range spans $2.69 to $5.83, and annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.96 | $3.96 | $5.18 | 0% | Neutral | |
| $2.72 | $3.79 | $5.69 | -4% | Neutral | |
| $2.81 | $4.14 | $6.62 | +5% | Neutral | |
| $3.24 | $5.03 | $8.44 | +27% | Bullish | |
| $3.82 | $6.22 | $10.84 | +57% | Bullish | |
| $3.30 | $5.60 | $10.10 | +41% | Bullish | |
| $2.68 | $4.74 | $8.82 | +20% | Neutral | |
| $2.84 | $5.24 | $10.00 | +32% | Bullish | |
| $2.51 | $4.83 | $9.45 | +22% | Bullish | |
| $3.14 | $6.27 | $12.56 | +58% | Bullish | |
| $2.60 | $5.78 | $12.72 | +46% | Bullish | |
| $7.40 | $16.45 | $37.84 | +315% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.96 | $3.96 | $4.72 | +0.00% |
| June 2026 | $3.28 | $3.94 | $4.89 | -0.53% |
| July 2026 | $2.91 | $3.55 | $4.53 | -9.79% |
| August 2026 | $2.75 | $3.40 | $4.41 | -4.39% |
| September 2026 | $2.91 | $3.64 | $4.80 | +7.16% |
| October 2026 | $2.92 | $3.69 | $4.93 | +1.30% |
| November 2026 | $2.79 | $3.56 | $4.82 | -3.50% |
| December 2026 | $2.94 | $3.78 | $5.18 | +6.31% |
Click any year to see its month-by-month CING forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cingulate Inc.'s 2026 outlook centres on $3.96, within a $3.96 to $5.18 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CING could reach as high as $5.69, with a base case around $3.79 and support toward $2.72 — roughly -4% from $3.96. A consolidation phase looks the most probable path here.
Expect CING to range from $2.81 to $6.62 through 2028. The $4.14 average target implies a +5% move from current prices. That is up +9% on the projected 2027 average. Price action looks broadly range-bound.
The CING price prediction for 2029 points to an average of $5.03 (low $3.24, high $8.44) — a potential gain of +27% on today's $3.96. Buyers look set to stay in control over this stretch.
In 2030, CING is projected to trade between $3.82 and $10.84, averaging $6.22 — a potential gain of +57% from today's $3.96. That is up +23% on the projected 2029 average. Momentum favours further upside here.
Cingulate Inc.'s 2031 outlook centres on $5.60, within a $3.30 to $10.10 range. That is -10% versus the projected 2030 average. That marks a +41% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CING could reach as high as $8.82, with a base case around $4.74 and support toward $2.68 — roughly +20% from $3.96. Price action looks broadly range-bound.
Expect CING to range from $2.84 to $10.00 through 2033. The $5.24 average target implies a +32% move from current prices. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CING price prediction for 2034 points to an average of $4.83 (low $2.51, high $9.45) — a potential gain of +22% on today's $3.96. Momentum favours further upside here.
In 2035, CING is projected to trade between $3.14 and $12.56, averaging $6.27 — a potential gain of +58% from today's $3.96. That is up +30% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cingulate Inc.'s 2040 outlook centres on $5.78, within a $2.60 to $12.72 range. That is -8% versus the projected 2035 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2050, CING could reach as high as $37.84, with a base case around $16.45 and support toward $7.40 — roughly +315% from $3.96. Buyers look set to stay in control over this stretch.
Investing $1,000 in CING today (≈ 252.525253 CING) could be worth
$4,154.62
+$3,154.62 (+315%) by 2050 · US Dollar
Based on the average projected CING price of $16.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CINGwould be worth at today's price.
$1,000 invested in CING on May 27, 2025 (≈ 272.479558 CING) would be worth
$1,079.02
+$79.02 (+7.9%) today · 1.08× · US Dollar
Based on a CING entry price of $3.67 vs. today's $3.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.63 | $855.29 | -14.5% |
| 1 month ago | $5.26 | $752.85 | -24.7% |
| 3 months ago | $6.49 | $610.17 | -39.0% |
| 6 months ago | $3.73 | $1,061.66 | +6.2% |
| 1 year ago | $3.67 | $1,079.02 | +7.9% |
| All time (4.5y) ago | $1,068 | $3.71 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CING forecast.
Our base-case forecast reaches $7.90 around 2050.
Implied market cap at $7.90: $104.88M
The multi-year forecast shows a generally bullish trajectory into the late 2020s and beyond. The 2030 forecast lists an avg price of $6.22 with a min of $3.82 and a max of $10.84, and an ROI of 57 with a bullish sentiment. By 2040, the avg is $5.78 with a min of $2.60 and a max of $12.72, and an ROI of 46 with a bullish sentiment.
By 2050, the forecast envisions an avg of $16.45 and a max of $37.84, with an ROI of 315.5 and a bullish sentiment. These projections illustrate substantial long-term upside potential, but they are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows a min of $3.82, an avg of $6.22, a max of $10.84, with a ROI of 57 and a bullish sentiment.
Near term is NEUTRAL with a current price of $3.96 and a market cap of $52.57M. The forecast ranges from a neutral stance in 2026-2028 to bullish in 2029-2050, with the 2030 avg $6.22 and 2050 avg $16.45, and a max in 2050 of $37.84, representing upside from today.
Yes. The 2030 forecast lists a max of $10.84.
Current price is $3.96. Market cap is $52.57M.
The 30-day range is $2.69 to $5.83.
Cingulate Inc. Community Discussion
0Share your Cingulate Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.